AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illumina
ILMN
|
+$489M |
| 2 |
PayPal
PYPL
|
+$464M |
| 3 |
Dollar General
DG
|
+$438M |
| 4 |
Synopsys
SNPS
|
+$432M |
| 5 |
MSCI
MSCI
|
+$414M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$887M |
| 2 |
Meta Platforms (Facebook)
META
|
+$589M |
| 3 |
Apple
AAPL
|
+$474M |
| 4 |
Nike
NKE
|
+$451M |
| 5 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
+$343M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.94% |
| 2 | Healthcare | 18.36% |
| 3 | Financials | 13.63% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Industrials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Arbutus Biopharma
ABUS
$871M
| $114K | ﹤0.01% |
49,100
+17,300
| +54% | +$41.4K |
|
|
AKYA
3102
DELISTED
Akoya BioSciences
AKYA
| $113K | ﹤0.01% |
+11,800
| New | +$145K |
|
|
CYXT
3103
DELISTED
Cyxtera Technologies, Inc. Class A Common Stock
CYXT
| $112K | ﹤0.01% |
58,500
+18,982
| +48% | +$44.8K |
|
3104
BuzzFeed
BZFD
$94.1M
| $110K | ﹤0.01% |
39,802
| – | – |
|
|
VLDR
3105
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
| $108K | ﹤0.01% |
145,900
+38,200
| +35% | +$36.1K |
|
3106
Future Fuel
FF
$203M
| $107K | ﹤0.01% |
13,217
+1,422
| +12% | +$10.7K |
|
3107
UNIFI
UFI
$121M
| $107K | ﹤0.01% |
12,400
-1,897
| -13% | -$16.3K |
|
3108
Relmada Therapeutics
RLMD
$546M
| $106K | ﹤0.01% |
30,400
+12,500
| +70% | +$110K |
|
|
SILV
3109
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $106K | ﹤0.01% |
17,652
| – | – |
|
|
MMX
3110
DELISTED
Maverix Metals Inc. Common Shares
MMX
| $104K | ﹤0.01% |
22,260
| – | – |
|
3111
CleanSpark
CLSK
$3.6B
| $101K | ﹤0.01% |
49,300
+33,600
| +214% | +$87K |
|
|
ORLA
3112
Orla Mining
ORLA
$3.56B
| $99.4K | ﹤0.01% |
24,600
| – | – |
|
3113
NextNav
NN
$1.73B
| $95.5K | ﹤0.01% |
32,600
+12,400
| +61% | +$38.1K |
|
3114
Babcock & Wilcox
BW
$1.4B
| $94.6K | ﹤0.01% |
+16,400
| New | +$89.6K |
|
3115
Monte Rosa Therapeutics
GLUE
$1.91B
| $94.4K | ﹤0.01% |
+12,400
| New | +$103K |
|
3116
Tango Therapeutics
TNGX
$4.35B
| $94.3K | ﹤0.01% |
+13,000
| New | +$91.4K |
|
3117
RLX Technology
RLX
$2.49B
| $93.3K | ﹤0.01% |
+40,580
| New | +$72K |
|
3118
Rimini Street
RMNI
$432M
| $92.2K | ﹤0.01% |
24,200
+11,000
| +83% | +$48.8K |
|
|
WE
3119
DELISTED
WeWork Inc.
WE
| $92.2K | ﹤0.01% |
1,612
-1,311
| -45% | -$123K |
|
|
MAGN
3120
Magnera Corp
MAGN
$490M
| $89.3K | ﹤0.01% |
2,470
+830
| +51% | +$33.9K |
|
|
ROVR
3121
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $86.6K | ﹤0.01% |
23,600
+11,400
| +93% | +$48.9K |
|
3122
Evolv Technologies
EVLV
$980M
| $86.5K | ﹤0.01% |
33,400
+5,600
| +20% | +$16.5K |
|
|
EXK
3123
Endeavour Silver
EXK
$2.35B
| $85.9K | ﹤0.01% |
26,500
| – | – |
|
|
DDL
3124
Dingdong
DDL
$523M
| $85.3K | ﹤0.01% |
+19,980
| New | +$78.4K |
|
|
CURO
3125
DELISTED
CURO Group Holdings Corp.
CURO
| $84.5K | ﹤0.01% |
23,800
+1,800
| +8% | +$6.86K |
|
Similar funds
AllianceBernstein's Q4 2022 Portfolio in Review
As of Q4 2022, AllianceBernstein held 3,394 positions worth $222B, up 7.6% from $207B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
AllianceBernstein's Q4 2022 filing shows 124 new, 1,572 increased, 1,272 reduced and 134 closed positions. Its largest new stake was Unilever: 2,996,697 shares worth $170M. The largest sale was Alphabet (Google) Class C, an estimated $887M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
- AllianceBernstein's largest Q4 2022 buy was Unilever: 2,996,697 shares worth $170M.
- AllianceBernstein added most to Illumina in Q4 2022, an estimated $489M increase.
- AllianceBernstein's biggest Q4 2022 reduction was Alphabet (Google) Class C, cutting an estimated $887M.
- AllianceBernstein fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $343M.
- AllianceBernstein's ten largest holdings make up 21% of its $222B portfolio in Q4 2022.
- AllianceBernstein opened 124 new positions and closed 134 in Q4 2022.
- AllianceBernstein's portfolio value rose 7.6% quarter-over-quarter to $222B.
Based on AllianceBernstein's 13F filing for Q4 2022, filed 15 Feb 2023.